German biotech opens US office to expand its global presence 05-Feb-2019 By Maggie Lynch Sirion Biotech has opened a US-based office to support local gene therapy research and clinical development with viral vector contract manufacturing.
Brammer Bio advancing 3 year, $200m program: 700 employees expected by mid-2019 27-Sep-2018 By Melissa Fassbender Brammer Bio’s three-year, $200m investment program is set to establish more than 30 suites for both clinical and commercial viral vector supply.
